Source: Eur Respir J 2010; 36: 856-863
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Vallès X., Roca A., Lozano F., Morais L., Suárez B., Casals F., Mandomando I., Sigaúque B., Nhalungo D., Esquinas C., Quintó L., Alonso P.L., Torres A.. Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J 2010; 36: 856-863

Member's Comments

No comment yet.

Related content which might interest you: The role of mannose-binding lectin in pneumococcal infection Source: Eur Respir J 2013; 41: 131-139 Year: 2013 Mannose-binding lectin and IgG receptor polymorphisms in COPD Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001 Relevance of mannose-binding lectin (MBL) polymorphism in repeated respiratory infections Source: Eur Respir J 2001; 18: Suppl. 33, 465s Year: 2001 Ficolins and mannose-binding lectin in Danish patients with sarcoidosis Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Immunoglobulin G antibodies to pneumococcal surface protein A (PspA) families in serum of adults with pneumococcal community-acquired pneumonia in China Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine Source: Eur Respir J 2002; 20: 813-818 Year: 2002 Prevalence of mannose-binding lectin variant alleles among cystic fibrosis patients in Italy Source: Eur Respir J 2002; 20: Suppl. 38, 339s Year: 2002 Impaired serum opsonisation of non typeable Haemophilus influenzae in COPD and Alpha-1 Anti-Trypsin Deficiency. A potential mechanism for reduced bacterial clearance? Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Dose serum mannose binding lectin (MBL) influence allergic disorders? Source: Eur Respir J 2004; 24: Suppl. 48, 395s Year: 2004 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease Source: ERJ Open Res, 4 (3) 00033-2018; 10.1183/23120541.00033-2018 Year: 2018 Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 673s Year: 2005 Impact of mannose-binding lectin deficiency on clinical course of cystic fibrosis in Southern Italy Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 Mannose-binding lectin (MBL) insufficiency in children with chronic obstructive pulmonary disease post-adenovirus infection (COPDadv) Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006 Downregulation of RTI40 /T1α protein in pneumococcal pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 719s Year: 2004 Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Plasma concentration of mannose-binding lectin in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 43s Year: 2005 Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 599s Year: 2006 Mannose binding lectin (MBL) levels predict lung function decline in severe asthma Source: Eur Respir Rev 2006; 15: 224-225 Year: 2006 Immunity to pneumococcal disease Source: Annual Congress 2013 –New understanding of pneumococcal vaccination Year: 2013